首页 > 最新文献

Digestive Endoscopy最新文献

英文 中文
Endoscopic ultrasound-guided vascular interventions 内窥镜超声引导下的血管介入治疗。
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-25 DOI: 10.1111/den.14925
Atsushi Irisawa, Kazunori Nagashima, Akira Yamamiya, Yoko Abe, Takumi Maki, Ken Kashima, Yasuhito Kunogi, Koh Fukushi, Fumi Sakuma, Yasunori Inaba, Keiichi Tominaga

With the recent development of interventional endoscopic ultrasound (EUS), EUS-guided vascular interventions have seen increased clinical and research focus. This modality can be used to diagnose portal hypertension and treat portal hypertension-related gastrointestinal varices and refractory gastrointestinal hemorrhage, including pseudoaneurysm. The vascular embolic materials used for treatment include tissue adhesives (cyanoacrylates), sclerosants, thrombin, and vascular embolic coils, all of which are associated with favorable results. The feasibility of EUS-guided procedures, including portal vein stenting and portosystemic shunt formation conventionally performed percutaneously and transvenously, has also been demonstrated, albeit in animal studies. As EUS-guided vascular intervention is a technique that may receive significant attention in the future, we provide a thorough review of the current evidence for its use.

随着近年来介入性内窥镜超声(EUS)的发展,EUS引导下的血管介入治疗已成为临床和研究的重点。这种方式可用于诊断门静脉高压症,治疗与门静脉高压症相关的消化道静脉曲张和难治性消化道出血,包括假性动脉瘤。用于治疗的血管栓塞材料包括组织粘合剂(氰基丙烯酸酯)、硬化剂、凝血酶和血管栓塞线圈,所有这些材料都有良好的效果。尽管是在动物实验中,但 EUS 引导的手术(包括传统的经皮和经静脉门静脉支架植入术和门静脉分流术)的可行性也已得到证实。由于 EUS 引导下的血管介入是一种未来可能会受到广泛关注的技术,因此我们对其应用的现有证据进行了全面回顾。
{"title":"Endoscopic ultrasound-guided vascular interventions","authors":"Atsushi Irisawa,&nbsp;Kazunori Nagashima,&nbsp;Akira Yamamiya,&nbsp;Yoko Abe,&nbsp;Takumi Maki,&nbsp;Ken Kashima,&nbsp;Yasuhito Kunogi,&nbsp;Koh Fukushi,&nbsp;Fumi Sakuma,&nbsp;Yasunori Inaba,&nbsp;Keiichi Tominaga","doi":"10.1111/den.14925","DOIUrl":"10.1111/den.14925","url":null,"abstract":"<p>With the recent development of interventional endoscopic ultrasound (EUS), EUS-guided vascular interventions have seen increased clinical and research focus. This modality can be used to diagnose portal hypertension and treat portal hypertension-related gastrointestinal varices and refractory gastrointestinal hemorrhage, including pseudoaneurysm. The vascular embolic materials used for treatment include tissue adhesives (cyanoacrylates), sclerosants, thrombin, and vascular embolic coils, all of which are associated with favorable results. The feasibility of EUS-guided procedures, including portal vein stenting and portosystemic shunt formation conventionally performed percutaneously and transvenously, has also been demonstrated, albeit in animal studies. As EUS-guided vascular intervention is a technique that may receive significant attention in the future, we provide a thorough review of the current evidence for its use.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 1","pages":"85-92"},"PeriodicalIF":5.0,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14925","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase concept: Novel dynamic endoscopic assessment of intramural antireflux mechanisms (with video) 阶段概念:新颖的动态内窥镜评估壁内反流机制(附视频)。
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-22 DOI: 10.1111/den.14922
Haruhiro Inoue, Mayo Tanabe, Yuto Shimamura, Kazuki Yamamoto, Yohei Nishikawa, Kei Ushikubo, Miyuki Iwasaki, Hidenori Tanaka, Ippei Tanaka, Kaori Owada, Satoshi Abiko, Manabu Onimaru, Stefan Seewald

Objectives

The gastroesophageal junction (GEJ) consists of various anatomical components that together form a barrier to prevent reflux of gastric content. This study introduces a novel phase concept to dynamically evaluate the antireflux barrier (ARB) during endoscopy and analyzes its functionality.

Methods

We reviewed previously the recorded endoscopic videos of subjects who underwent the endoscopic pressure study integrated system (EPSIS) from February to April 2024 for indications other than gastroesophageal reflux disease symptoms. This device was used as an auxiliary tool to measure intragastric pressure (IGP) during endoscopy with a retroflex view. The ARB dynamic was divided into three phases: Phase I (gastric phase), Phase II (lower esophageal sphincter phase), and Phase III (esophageal clearance phase). We evaluated the morphological changes in the ARB during insufflation using EPSIS.

Results

The median age of the 30 subjects was 58 years (interquartile range [IQR] 46.5–68.8), including 20 men and 10 women. Endoscopic findings and IGPs were recorded during the three phases. In Phase I, at low IGP (median 6.75 mmHg), the gastroesophageal flap valve and longitudinal folds were observed in 80% of cases. In Phase II, at moderate IGP (median 11.8 mmHg), the scope holding sign was observed in 86.7%. In Phase III, at high IGP (median 19 mmHg) inducing belching, peristalsis was observed in 80% of cases with median recovery time of 5 s.

Conclusion

The phase concept provides a valuable framework for understanding the antireflux mechanism. Further research is needed to validate these findings in GEJ disorders and explore correlations with other modalities.

目的:胃食管交界处(GEJ)由各种解剖成分组成,共同构成防止胃内容物反流的屏障。本研究引入了一种新的阶段概念,在内窥镜检查过程中动态评估抗反流屏障(ARB)并分析其功能:我们回顾了之前录制的内窥镜视频,这些受试者在 2024 年 2 月至 4 月期间因胃食管反流疾病症状以外的适应症接受了内窥镜压力研究综合系统(EPSIS)检查。该设备作为一种辅助工具,用于在内窥镜检查过程中以反向视角测量胃内压(IGP)。ARB 动态测量分为三个阶段:第一阶段(胃期)、第二阶段(食管下括约肌期)和第三阶段(食管清除期)。我们使用 EPSIS 评估了充气过程中 ARB 的形态变化:结果:30 名受试者的中位年龄为 58 岁(四分位数间距 [IQR] 46.5-68.8),其中男性 20 人,女性 10 人。三个阶段均记录了内窥镜检查结果和 IGP。在第一阶段,当 IGP 较低时(中位数为 6.75 mmHg),80% 的病例都能观察到胃食管瓣膜和纵向皱褶。第二阶段,在中度 IGP(中位数 11.8 mmHg)时,86.7% 的病例观察到范围保持征。在第三阶段,当高 IGP(中位数 19 mmHg)诱发嗳气时,80% 的病例观察到蠕动,中位恢复时间为 5 秒:阶段概念为了解抗反流机制提供了一个有价值的框架。结论:相位概念为了解抗反流机制提供了宝贵的框架,需要进一步研究在胃食管返流紊乱中验证这些发现,并探索与其他模式的相关性。
{"title":"Phase concept: Novel dynamic endoscopic assessment of intramural antireflux mechanisms (with video)","authors":"Haruhiro Inoue,&nbsp;Mayo Tanabe,&nbsp;Yuto Shimamura,&nbsp;Kazuki Yamamoto,&nbsp;Yohei Nishikawa,&nbsp;Kei Ushikubo,&nbsp;Miyuki Iwasaki,&nbsp;Hidenori Tanaka,&nbsp;Ippei Tanaka,&nbsp;Kaori Owada,&nbsp;Satoshi Abiko,&nbsp;Manabu Onimaru,&nbsp;Stefan Seewald","doi":"10.1111/den.14922","DOIUrl":"10.1111/den.14922","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The gastroesophageal junction (GEJ) consists of various anatomical components that together form a barrier to prevent reflux of gastric content. This study introduces a novel phase concept to dynamically evaluate the antireflux barrier (ARB) during endoscopy and analyzes its functionality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We reviewed previously the recorded endoscopic videos of subjects who underwent the endoscopic pressure study integrated system (EPSIS) from February to April 2024 for indications other than gastroesophageal reflux disease symptoms. This device was used as an auxiliary tool to measure intragastric pressure (IGP) during endoscopy with a retroflex view. The ARB dynamic was divided into three phases: Phase I (gastric phase), Phase II (lower esophageal sphincter phase), and Phase III (esophageal clearance phase). We evaluated the morphological changes in the ARB during insufflation using EPSIS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The median age of the 30 subjects was 58 years (interquartile range [IQR] 46.5–68.8), including 20 men and 10 women. Endoscopic findings and IGPs were recorded during the three phases. In Phase I, at low IGP (median 6.75 mmHg), the gastroesophageal flap valve and longitudinal folds were observed in 80% of cases. In Phase II, at moderate IGP (median 11.8 mmHg), the scope holding sign was observed in 86.7%. In Phase III, at high IGP (median 19 mmHg) inducing belching, peristalsis was observed in 80% of cases with median recovery time of 5 s.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The phase concept provides a valuable framework for understanding the antireflux mechanism. Further research is needed to validate these findings in GEJ disorders and explore correlations with other modalities.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 3","pages":"257-265"},"PeriodicalIF":5.0,"publicationDate":"2024-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14922","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Failed endoscopic ultrasound-guided gallbladder drainage across the duodenal covered metallic stent salvaged by using a forward-viewing linear echoendoscope 使用前视线性回声内窥镜挽救了内窥镜超声引导胆囊引流失败的十二指肠金属支架。
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-18 DOI: 10.1111/den.14931
Tesshin Ban, Yoshimasa Kubota, Takashi Joh

Endoscopic ultrasonography-guided gallbladder drainage (EUS-GBD) has emerged as an alternative to standard percutaneous or transpapillary approaches in fragile patients with acute cholecystitis.1-3 Oblique-viewing linear endoscopic ultrasonography (OV-EUS) is used for biliary intervention. However, forward-viewing linear endoscopic ultrasonography (FV-EUS) is applied in certain settings.4, 5 Herein, we report salvaged EUS-GBD by using FV-EUS after failure of OV-EUS.

An 82-year-old man with clinical stage IV pancreatic cancer presented with severe vomiting and initially underwent implantation of a duodenal bulb-covered metallic stent. One week later, this patient underwent endoscopic ultrasonography-guided choledochoduodenostomy due to acute obstructive suppurative cholangitis without intrahepatic biliary dilation (Video S1). One month later, this patient developed antibiotic-refractory acute cholecystitis, which deteriorated into a pericholecystic abscess (Fig. 1). Prioritizing the internal drainage, we attempted EUS-GBD using OV-EUS (EG-580UT; Fujifilm, Tokyo, Japan). The gallbladder was depicted; however, the scope struggled to maneuver in the duodenal metallic stent, and a 19G lancet puncture needle could not advance from the scope channel into the gallbladder (Fig. 2a, Video S1). The following day, we retried EUS-GBD using FV-EUS (TGF-UC260J; Olympus, Tokyo, Japan), which quickly facilitated the gallbladder visualization, needle puncture, 0.025 inch hydrophilic guidewire advancement, electrocautery dilation (Cysto-Gastro-Sets; Endo-flex, Voerde, Germany), and a double-pigtailed plastic stent deployment (Advanix J, 7F, 7 cm; Boston Scientific, Marlborough, MA, USA) (Fig. 2b,c, Video S1). The clinical course was uneventful.

The maneuverability of the OV-EUS was limited inside the duodenal bulb stent. We needed to down-angle the scope steeply to depict the gallbladder, which obstructed the puncture needle. In this situation, FV-EUS in the long position easily depicted the gallbladder without an angle maneuver. In addition, all the devices showed excellent pushability and trackability, including the puncture needle, dilator, and gallbladder stent, because the target was located vertically in front of the long-positioned FV-EUS.5

Authors declare no conflict of interest for this article.

超声内镜引导下的胆囊引流术(EUS-GBD)已成为急性胆囊炎脆弱患者经皮或经乳头入路的替代方法。1-3斜视线性超声内镜(OV-EUS)用于胆道介入检查。然而,前视线性内窥镜超声检查(FV-EUS)在某些情况下应用。4,5在此,我们报道在OV-EUS失败后使用FV-EUS挽救EUS-GBD。一位82岁的临床IV期胰腺癌患者表现为严重呕吐,最初接受了十二指肠球茎覆盖金属支架的植入。一周后,患者因急性梗阻性化脓性胆管炎,无肝内胆道扩张,行超声内镜下胆道十二指肠切开术(视频S1)。1个月后,该患者出现抗生素难治性急性胆囊炎,并恶化为胆囊周围脓肿(图1)。我们优先考虑内部引流,采用OV-EUS (EG-580UT;富士胶片,东京,日本)。画的是胆囊;然而,内镜在十二指肠金属支架内难以移动,19G柳叶刀穿刺针无法从内镜通道进入胆囊(图2a,视频S1)。第二天,我们用FV-EUS (TGF-UC260J;奥林巴斯,东京,日本),这迅速促进了胆囊的可视化,针穿刺,0.025英寸亲水导丝推进,电灼扩张(膀胱-胃-套;Endo-flex, Voerde, Germany)和双尾塑料支架部署(Advanix J, 7F, 7cm;Boston Scientific, Marlborough, MA, USA)(图2b,c,视频S1)。临床过程平淡无奇。在十二指肠球状支架内,OV-EUS的可操作性受到限制。我们需要将瞄准镜的角度急剧向下以显示胆囊,因为胆囊挡住了穿刺针。在这种情况下,FV-EUS在没有角度操纵的情况下很容易描绘胆囊。此外,所有的装置,包括穿刺针、扩张器和胆囊支架,都表现出良好的可推进性和可追踪性,因为目标垂直位于长位置的FV-EUS前面。作者声明本文无利益冲突。
{"title":"Failed endoscopic ultrasound-guided gallbladder drainage across the duodenal covered metallic stent salvaged by using a forward-viewing linear echoendoscope","authors":"Tesshin Ban,&nbsp;Yoshimasa Kubota,&nbsp;Takashi Joh","doi":"10.1111/den.14931","DOIUrl":"10.1111/den.14931","url":null,"abstract":"<p>Endoscopic ultrasonography-guided gallbladder drainage (EUS-GBD) has emerged as an alternative to standard percutaneous or transpapillary approaches in fragile patients with acute cholecystitis.<span><sup>1-3</sup></span> Oblique-viewing linear endoscopic ultrasonography (OV-EUS) is used for biliary intervention. However, forward-viewing linear endoscopic ultrasonography (FV-EUS) is applied in certain settings.<span><sup>4, 5</sup></span> Herein, we report salvaged EUS-GBD by using FV-EUS after failure of OV-EUS.</p><p>An 82-year-old man with clinical stage IV pancreatic cancer presented with severe vomiting and initially underwent implantation of a duodenal bulb-covered metallic stent. One week later, this patient underwent endoscopic ultrasonography-guided choledochoduodenostomy due to acute obstructive suppurative cholangitis without intrahepatic biliary dilation (Video S1). One month later, this patient developed antibiotic-refractory acute cholecystitis, which deteriorated into a pericholecystic abscess (Fig. 1). Prioritizing the internal drainage, we attempted EUS-GBD using OV-EUS (EG-580UT; Fujifilm, Tokyo, Japan). The gallbladder was depicted; however, the scope struggled to maneuver in the duodenal metallic stent, and a 19G lancet puncture needle could not advance from the scope channel into the gallbladder (Fig. 2a, Video S1). The following day, we retried EUS-GBD using FV-EUS (TGF-UC260J; Olympus, Tokyo, Japan), which quickly facilitated the gallbladder visualization, needle puncture, 0.025 inch hydrophilic guidewire advancement, electrocautery dilation (Cysto-Gastro-Sets; Endo-flex, Voerde, Germany), and a double-pigtailed plastic stent deployment (Advanix J, 7F, 7 cm; Boston Scientific, Marlborough, MA, USA) (Fig. 2b,c, Video S1). The clinical course was uneventful.</p><p>The maneuverability of the OV-EUS was limited inside the duodenal bulb stent. We needed to down-angle the scope steeply to depict the gallbladder, which obstructed the puncture needle. In this situation, FV-EUS in the long position easily depicted the gallbladder without an angle maneuver. In addition, all the devices showed excellent pushability and trackability, including the puncture needle, dilator, and gallbladder stent, because the target was located vertically in front of the long-positioned FV-EUS.<span><sup>5</sup></span></p><p>Authors declare no conflict of interest for this article.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"36 12","pages":"1389-1390"},"PeriodicalIF":5.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14931","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142256012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WEO Newsletter: ENDO 2024 was a great success! Thanks to all who participated 世界工程师组织通讯:ENDO2024取得了巨大成功!感谢所有参与者
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-12 DOI: 10.1111/den.14920
<p>Professor Hisao Tajiri, WEO and ENDO 2024 President made the following statement:</p><p>“ENDO 2024 had 3200 participants from all over the world despite the current medical strike happening in Korea, and we were able to have an intimate international exchange through many symposia, live demonstrations, hands-on courses, receptions, and so on. Many young doctors from developing countries in Asia also participated in the Congress. I believe that our WEO was instrumental in fulfilling its mission in terms of education for developing countries.</p><p>I sincerely appreciate the strong support of Prof Hoon Jai Chun, ENDO 2024 Congress Co-President and Prof Jong-Jae Park, President of KSGE [Korean Society of Gastrointestinal Endoscopy] and IDEN [International Digestive Endoscopy Network], and many other doctors involved in KSGE.</p><p>And I also thank organizing committee members of ENDO 2024, Dr. Jean-Francois Rey, Chair of the Steering Committee, Drs. Philip Chiu and Jong Ho Moon, Chair and Co-Chair of the Scientific Committee, Dr. Robert Hawes, Treasurer, Dr. Yutaka Saito, WEO Secretary General, colleagues in Japan, and all other organizing committee members including WEO office staff. I would like to express my sincere gratitude to all of them.</p><p>From Seoul, Korea, through the top experts of GI endoscopy, new insights and bright futures were brought to many endoscopists. I believe that the three-day program met the expectations of all gastroenterologists, endoscopists, and nurses who participated in ENDO 2024. The overwhelming response we have received from the participants, faculty, and industry alike is a great testament to the quality of the Congress and its high relevance to continuing education and to medical advancement; the initiation of both of those is part of WEO's mission, as well as maintaining the quality of endoscopic teaching.</p><p>Some highlights of ENDO 2024 included six outstanding live demonstrations and discussions from three international and three of the most advanced Korean centers, 22 hands-on training stations, 8 of WEO's best-established educational courses, 10 joint symposia with our global partners, 5 KSGE-IDEN sessions and 2 young endoscopist forums, 17 sessions presenting the ENDO 2024 best oral abstracts, and 23 innovative industry symposia.</p><p>ENDO 2024 was honored to host several distinguished educational lectures, by Joo Young Cho (Korea), Fabian Emura (Colombia), Ian Gralnek (Israel), and Nageshwar Reddy (India).</p><p>As is traditional at ENDO congresses, the learning track offered well-established WEO courses including the Advanced Diagnosis Endoscopy Course (ADEC), Colorectal Cancer Screening Committee meetings, WEO International School of Endoscopy (WISE) sessions, the Research Forum, Video Capsule Endoscopy (VCE) and High-Q courses. A Women in Endoscopy session was held for the first time, covering gender-related aspects of endoscopy. ENDO 2024 President Hisao Tajiri commemorated this as the last se
来自东京医科大学、大阪国际癌症研究所、佐野医院和独协医科大学医学部等日本知名机构的四个视频病例进行了现场讨论。近 80 篇顶级摘要的作者获得了 WEO 和我们的合作伙伴学会(日本消化内镜学会(JGES)、亚太消化内镜学会(A-PSDE)和中国消化内镜学会(CSDE))的资助。近 40 场科学会议和约 300 场专家演讲(包括荣誉讲座)为每位代表提供了符合其特定兴趣的学习体验。业界参与人数众多,各公司有机会展示其最新技术,并将ENDO 2024 作为与临床医生重新建立联系的最佳平台。WEO代表ENDO 2024主席Hisao Tajiri教授和ENDO 2024联合主席Hoon Jai Chun教授,感谢所有这些教师和合作学会为准备和介绍他们的会议所付出的辛勤劳动和时间。他们为ENDO 2024的成功做出了至关重要的贡献!此外,还要特别感谢所有与会者和业界的大力支持!ENDO 2024是独一无二的,真正特别的。再次感谢您的参与! 保持联系!WEO 活动日历。
{"title":"WEO Newsletter: ENDO 2024 was a great success! Thanks to all who participated","authors":"","doi":"10.1111/den.14920","DOIUrl":"https://doi.org/10.1111/den.14920","url":null,"abstract":"&lt;p&gt;Professor Hisao Tajiri, WEO and ENDO 2024 President made the following statement:&lt;/p&gt;&lt;p&gt;“ENDO 2024 had 3200 participants from all over the world despite the current medical strike happening in Korea, and we were able to have an intimate international exchange through many symposia, live demonstrations, hands-on courses, receptions, and so on. Many young doctors from developing countries in Asia also participated in the Congress. I believe that our WEO was instrumental in fulfilling its mission in terms of education for developing countries.&lt;/p&gt;&lt;p&gt;I sincerely appreciate the strong support of Prof Hoon Jai Chun, ENDO 2024 Congress Co-President and Prof Jong-Jae Park, President of KSGE [Korean Society of Gastrointestinal Endoscopy] and IDEN [International Digestive Endoscopy Network], and many other doctors involved in KSGE.&lt;/p&gt;&lt;p&gt;And I also thank organizing committee members of ENDO 2024, Dr. Jean-Francois Rey, Chair of the Steering Committee, Drs. Philip Chiu and Jong Ho Moon, Chair and Co-Chair of the Scientific Committee, Dr. Robert Hawes, Treasurer, Dr. Yutaka Saito, WEO Secretary General, colleagues in Japan, and all other organizing committee members including WEO office staff. I would like to express my sincere gratitude to all of them.&lt;/p&gt;&lt;p&gt;From Seoul, Korea, through the top experts of GI endoscopy, new insights and bright futures were brought to many endoscopists. I believe that the three-day program met the expectations of all gastroenterologists, endoscopists, and nurses who participated in ENDO 2024. The overwhelming response we have received from the participants, faculty, and industry alike is a great testament to the quality of the Congress and its high relevance to continuing education and to medical advancement; the initiation of both of those is part of WEO's mission, as well as maintaining the quality of endoscopic teaching.&lt;/p&gt;&lt;p&gt;Some highlights of ENDO 2024 included six outstanding live demonstrations and discussions from three international and three of the most advanced Korean centers, 22 hands-on training stations, 8 of WEO's best-established educational courses, 10 joint symposia with our global partners, 5 KSGE-IDEN sessions and 2 young endoscopist forums, 17 sessions presenting the ENDO 2024 best oral abstracts, and 23 innovative industry symposia.&lt;/p&gt;&lt;p&gt;ENDO 2024 was honored to host several distinguished educational lectures, by Joo Young Cho (Korea), Fabian Emura (Colombia), Ian Gralnek (Israel), and Nageshwar Reddy (India).&lt;/p&gt;&lt;p&gt;As is traditional at ENDO congresses, the learning track offered well-established WEO courses including the Advanced Diagnosis Endoscopy Course (ADEC), Colorectal Cancer Screening Committee meetings, WEO International School of Endoscopy (WISE) sessions, the Research Forum, Video Capsule Endoscopy (VCE) and High-Q courses. A Women in Endoscopy session was held for the first time, covering gender-related aspects of endoscopy. ENDO 2024 President Hisao Tajiri commemorated this as the last se","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"36 9","pages":"1062-1071"},"PeriodicalIF":5.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14920","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142231066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Troubleshooting the migration of endoscopic ultrasound-guided pancreatic duct drainage stent to avoid repuncture 解决内镜超声引导下胰管引流支架移位问题,避免再次穿刺
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-10 DOI: 10.1111/den.14906
Kazuki Hama, Reina Tanaka, Takao Itoi

Endoscopic ultrasound (EUS)-guided drainage effectively treats difficult transpapillary drainage.1, 2 However, EUS-guided pancreatic duct drainage (EUS-PD) is technically challenging, as repuncture should be avoided to prevent pancreatic fluid leakage; we describe a technique for EUS-PD stent migration that enables us to avoid repuncture (Video S1).3 A 54-year-old woman, who underwent pancreaticoduodenectomy for pancreatic cancer, experienced recurrent cholangitis and pancreatic stones due to anastomotic stenosis. Endoscopic drainage using a single-balloon enteroscope (SIF-H290S; Olympus, Tokyo, Japan) was attempted, but identifying the pancreatic duct orifice was difficult. Therefore, EUS-PD was performed to secure the route for stone removal. A 19G needle (EZ shot 3 plus; Olympus) was used to puncture the dilated pancreatic duct at the tail. The drill dilator (Tornus ES; Olympus) could not pass the stone. A 4 mm dilating balloon (REN TYPE-IT; Kaneka, Osaka, Japan) was used. After adequate dilation, a 7Fr plastic stent (TYPE IT; Gadelius Medical, Tokyo, Japan) was deployed, but its tip failed to cross the stone and anastomosis, so the stent was placed in the main pancreatic duct proximal to the stone.4 Vomiting and fever occurred postprocedure, and radiography revealed stent migration into the esophagus. However, computed tomography revealed the stent tip barely lodged in the pancreatic duct owing to the large flap. Therefore, using a side-viewing duodenoscope (TJF-260 V; Olympus), a guidewire (VisiGlide II; Olympus) was successfully inserted through the stent flap and guided into the jejunum. The stent was removed using forceps (Figs 1, 2). The tract and anastomotic site were sufficiently dilated using a drill dilator, and a 6 mm fully covered self-expandable metal stent (EGIS biliary stent, 6 × 10 mm; SB-Kawsumi, Kanagawa, Japan) was successfully placed. One month later, the stone was successfully removed by the EUS-PD route. A plastic stent has two large flaps at its tip, and even if it migrates, the flap may remain in the pancreas.

Author T.I. received honoraria for his lectures from Olympus and Boston Scientific. The other authors declare no conflict of interest for this article.

观看本文视频。
{"title":"Troubleshooting the migration of endoscopic ultrasound-guided pancreatic duct drainage stent to avoid repuncture","authors":"Kazuki Hama,&nbsp;Reina Tanaka,&nbsp;Takao Itoi","doi":"10.1111/den.14906","DOIUrl":"10.1111/den.14906","url":null,"abstract":"<p>Endoscopic ultrasound (EUS)-guided drainage effectively treats difficult transpapillary drainage.<span><sup>1, 2</sup></span> However, EUS-guided pancreatic duct drainage (EUS-PD) is technically challenging, as repuncture should be avoided to prevent pancreatic fluid leakage; we describe a technique for EUS-PD stent migration that enables us to avoid repuncture (Video S1).<span><sup>3</sup></span> A 54-year-old woman, who underwent pancreaticoduodenectomy for pancreatic cancer, experienced recurrent cholangitis and pancreatic stones due to anastomotic stenosis. Endoscopic drainage using a single-balloon enteroscope (SIF-H290S; Olympus, Tokyo, Japan) was attempted, but identifying the pancreatic duct orifice was difficult. Therefore, EUS-PD was performed to secure the route for stone removal. A 19G needle (EZ shot 3 plus; Olympus) was used to puncture the dilated pancreatic duct at the tail. The drill dilator (Tornus ES; Olympus) could not pass the stone. A 4 mm dilating balloon (REN TYPE-IT; Kaneka, Osaka, Japan) was used. After adequate dilation, a 7Fr plastic stent (TYPE IT; Gadelius Medical, Tokyo, Japan) was deployed, but its tip failed to cross the stone and anastomosis, so the stent was placed in the main pancreatic duct proximal to the stone.<span><sup>4</sup></span> Vomiting and fever occurred postprocedure, and radiography revealed stent migration into the esophagus. However, computed tomography revealed the stent tip barely lodged in the pancreatic duct owing to the large flap. Therefore, using a side-viewing duodenoscope (TJF-260 V; Olympus), a guidewire (VisiGlide II; Olympus) was successfully inserted through the stent flap and guided into the jejunum. The stent was removed using forceps (Figs 1, 2). The tract and anastomotic site were sufficiently dilated using a drill dilator, and a 6 mm fully covered self-expandable metal stent (EGIS biliary stent, 6 × 10 mm; SB-Kawsumi, Kanagawa, Japan) was successfully placed. One month later, the stone was successfully removed by the EUS-PD route. A plastic stent has two large flaps at its tip, and even if it migrates, the flap may remain in the pancreas.</p><p>Author T.I. received honoraria for his lectures from Olympus and Boston Scientific. The other authors declare no conflict of interest for this article.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"36 11","pages":"1288-1289"},"PeriodicalIF":5.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14906","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142195514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic ultrasound-guided gastrojejunostomy with wire endoscopic simplified technique: Move towards benign indications (with video) 内窥镜超声引导下的胃空肠吻合术与线内窥镜简化技术:向良性适应症发展(附视频)
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-10 DOI: 10.1111/den.14895
Jean-Michel Gonzalez, Sohaib Ouazzani, Geoffroy Vanbiervliet, Mohamed Gasmi, Marc Barthet

Objectives

Endoscopic ultrasound-guided gastrojejunostomy (EUS-GJ) is an alternative to duodenal stenting and surgical GJ (SGGJ) in malignant gastric outlet obstruction (MGOO). European Society of Gastrointestinal Endoscopy guidelines restricted EUS-GJ for MGOO only, because of misdeployment. The aim was to evaluate its outcomes focusing on benign indications.

Methods

This was a retrospective study conducted from 2016 to 2023 in a tertiary center. Patients included had malignant or benign GOO indicated for EUS-GJ. Techniques were the direct approach until August 2021, and the wire endoscopic simplified technique (WEST) afterwards. The main objective was to compare outcomes in benign vs. MGOO. Secondary end-points were technical success, adverse events rates, and describing the evolution of techniques and indications.

Results

In all, 87 patients were included, 46 men, mean age 66 ± 16.2 years. Indications were malignant in 60.1% and benign in 39.1%. The EUS-GJ technique was direct in 33 patients (37.9%) and WEST in 54 (62.1%). No difference was found in terms of technical, clinical, or adverse events rates. The initial technical success rate was 88.5%. The final technical and clinical success rates were 96.6% and 94.25%, respectively. In the last year, benign exceeded malignant indications (70.4% vs. 29.6%, P < 0.05). Seven misdeployments occurred, six being addressed with the rescue technique. The misdeployment rate was significantly decreased using the WEST approach compared to the direct one: 3.7% vs. 18% (P < 0.05). The severe postoperative adverse events rate was 2.3%.

Conclusion

This study demonstrated similar outcomes of EUS-GJ between benign and MGOO, with a decreasing misdeployment rate (<4%) applying WEST. This represents an additional step towards recommending EUS-GJ in benign indications.

目的内镜超声引导下胃空肠吻合术(EUS-GJ)是恶性胃出口梗阻(MGOO)十二指肠支架植入术和外科胃空肠吻合术(SGGJ)的替代方法。欧洲消化内镜学会的指南规定,EUS-GJ 只能用于 MGOO,因为会出现误操作。方法这是一项回顾性研究,于 2016 年至 2023 年在一家三级中心进行。纳入的患者有恶性或良性 GOO,均有 EUS-GJ 适应症。2021年8月前采用直接方法,2021年8月后采用线内镜简化技术(WEST)。主要目的是比较良性与恶性GOO的治疗效果。次要终点是技术成功率、不良事件发生率,以及描述技术和适应症的演变。60.1%的适应症为恶性,39.1%为良性。33例患者(37.9%)采用直接EUS-GJ技术,54例患者(62.1%)采用WEST技术。在技术、临床和不良事件发生率方面没有发现差异。最初的技术成功率为 88.5%。最终的技术和临床成功率分别为 96.6% 和 94.25%。去年,良性适应症超过了恶性适应症(70.4% 对 29.6%,P <0.05)。发生了七次错误部署,其中六次是通过抢救技术解决的。与直接方法相比,WEST方法的误置率明显降低:3.7%对18%(P< 0.05)。结论这项研究表明,良性和 MGOO 的 EUS-GJ 结果相似,采用 WEST 方法的误切率(<4%)有所下降。这表明在良性适应症中推荐使用 EUS-GJ 又迈进了一步。
{"title":"Endoscopic ultrasound-guided gastrojejunostomy with wire endoscopic simplified technique: Move towards benign indications (with video)","authors":"Jean-Michel Gonzalez,&nbsp;Sohaib Ouazzani,&nbsp;Geoffroy Vanbiervliet,&nbsp;Mohamed Gasmi,&nbsp;Marc Barthet","doi":"10.1111/den.14895","DOIUrl":"10.1111/den.14895","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Endoscopic ultrasound-guided gastrojejunostomy (EUS-GJ) is an alternative to duodenal stenting and surgical GJ (SGGJ) in malignant gastric outlet obstruction (MGOO). European Society of Gastrointestinal Endoscopy guidelines restricted EUS-GJ for MGOO only, because of misdeployment. The aim was to evaluate its outcomes focusing on benign indications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a retrospective study conducted from 2016 to 2023 in a tertiary center. Patients included had malignant or benign GOO indicated for EUS-GJ. Techniques were the direct approach until August 2021, and the wire endoscopic simplified technique (WEST) afterwards. The main objective was to compare outcomes in benign vs. MGOO. Secondary end-points were technical success, adverse events rates, and describing the evolution of techniques and indications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In all, 87 patients were included, 46 men, mean age 66 ± 16.2 years. Indications were malignant in 60.1% and benign in 39.1%. The EUS-GJ technique was direct in 33 patients (37.9%) and WEST in 54 (62.1%). No difference was found in terms of technical, clinical, or adverse events rates. The initial technical success rate was 88.5%. The final technical and clinical success rates were 96.6% and 94.25%, respectively. In the last year, benign exceeded malignant indications (70.4% vs. 29.6%, <i>P</i> &lt; 0.05). Seven misdeployments occurred, six being addressed with the rescue technique. The misdeployment rate was significantly decreased using the WEST approach compared to the direct one: 3.7% vs. 18% (<i>P</i> &lt; 0.05). The severe postoperative adverse events rate was 2.3%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study demonstrated similar outcomes of EUS-GJ between benign and MGOO, with a decreasing misdeployment rate (&lt;4%) applying WEST. This represents an additional step towards recommending EUS-GJ in benign indications.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 2","pages":"167-175"},"PeriodicalIF":5.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14895","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142195512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and safety of endoscopic full-thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video) 上消化道黏膜下肿瘤(主要包括腔外黏膜下肿瘤)内窥镜全厚切除术的可行性和安全性(附视频
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-10 DOI: 10.1111/den.14918
Yingjie Guo, Fan Yin, Xingsi Qi, Peng Zhang, Xueguo Sun, Xueli Ding, Xiaoyu Li, Xue Jing, Yueping Jiang, Zibin Tian, Tao Mao

Objectives

Endoscopic full-thickness resection (EFTR) for submucosal tumors (SMTs) has been technically challenging. This retrospective study aimed to evaluate the feasibility, safety, and efficacy of EFTR for upper gastrointestinal (GI) SMTs, including extraluminal lesions.

Methods

We retrospectively investigated 232 patients with SMTs who underwent EFTR from January 2014 to August 2023. Clinicopathologic characteristics, procedure-related parameters, adverse events (AEs), and follow-up outcomes were assessed in all patients.

Results

The en-bloc resection and en-bloc with R0 resection rates were 98.7% and 96.1%, respectively. The average endoscopic tumor size measured 17.2 ± 8.7 mm, ranging from 6 to 50 mm. The resection time and suture time were 49.0 ± 19.4 min and 22.5 ± 11.6 min, respectively. In all, 39 lesions (16.8%) exhibited predominantly extraluminal growth. Gastrointestinal stromal tumors (GISTs) were the predominant pathology, accounting for 78.4% of the cases. Twenty-one patients (9.1%) encountered complications, including pneumothorax (1/232, 0.43%), hydrothorax (1/232, 0.43%), localized peritonitis (3/232, 1.29%), and fever (16/232, 6.9%). Although the incidence of postoperative fever was notably higher in the predominantly extraluminal group (7/39, 17.9%) compared to the predominantly intraluminal group (9/193, 4.7%, P = 0.008), there were no significant differences in outcomes of the EFTR procedure. No instances of recurrence were observed during the mean follow-up period of 3.7 ± 2.3 years.

Conclusion

EFTR was found to be feasible, safe, and effective for resecting upper GI SMTs, including lesions with predominantly extraluminal growth. Further validation in a prospective study is warranted.

目的内镜下黏膜下肿瘤(SMT)全厚切除术(EFTR)在技术上具有挑战性。这项回顾性研究旨在评估 EFTR 治疗上消化道(GI)黏膜下肿瘤(包括腔外病变)的可行性、安全性和有效性。对所有患者的临床病理特征、手术相关参数、不良事件(AEs)和随访结果进行了评估。结果全层切除率和全层R0切除率分别为98.7%和96.1%。内镜下肿瘤平均大小为 17.2 ± 8.7 毫米,范围为 6 至 50 毫米。切除时间和缝合时间分别为(49.0 ± 19.4)分钟和(22.5 ± 11.6)分钟。总共有 39 个病灶(16.8%)主要表现为腔外生长。胃肠道间质瘤(GIST)是主要病理类型,占病例总数的78.4%。21名患者(9.1%)出现了并发症,包括气胸(1/232,0.43%)、气胸积水(1/232,0.43%)、局部腹膜炎(3/232,1.29%)和发热(16/232,6.9%)。虽然以腔外为主组的术后发热发生率(7/39,17.9%)明显高于以腔内为主组(9/193,4.7%,P = 0.008),但 EFTR 手术的结果并无显著差异。结论发现,EFTR 是切除上消化道 SMT(包括以腔外生长为主的病变)的可行、安全且有效的方法。需要在前瞻性研究中进一步验证。
{"title":"Feasibility and safety of endoscopic full-thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video)","authors":"Yingjie Guo,&nbsp;Fan Yin,&nbsp;Xingsi Qi,&nbsp;Peng Zhang,&nbsp;Xueguo Sun,&nbsp;Xueli Ding,&nbsp;Xiaoyu Li,&nbsp;Xue Jing,&nbsp;Yueping Jiang,&nbsp;Zibin Tian,&nbsp;Tao Mao","doi":"10.1111/den.14918","DOIUrl":"10.1111/den.14918","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Endoscopic full-thickness resection (EFTR) for submucosal tumors (SMTs) has been technically challenging. This retrospective study aimed to evaluate the feasibility, safety, and efficacy of EFTR for upper gastrointestinal (GI) SMTs, including extraluminal lesions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively investigated 232 patients with SMTs who underwent EFTR from January 2014 to August 2023. Clinicopathologic characteristics, procedure-related parameters, adverse events (AEs), and follow-up outcomes were assessed in all patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The en-bloc resection and en-bloc with R0 resection rates were 98.7% and 96.1%, respectively. The average endoscopic tumor size measured 17.2 ± 8.7 mm, ranging from 6 to 50 mm. The resection time and suture time were 49.0 ± 19.4 min and 22.5 ± 11.6 min, respectively. In all, 39 lesions (16.8%) exhibited predominantly extraluminal growth. Gastrointestinal stromal tumors (GISTs) were the predominant pathology, accounting for 78.4% of the cases. Twenty-one patients (9.1%) encountered complications, including pneumothorax (1/232, 0.43%), hydrothorax (1/232, 0.43%), localized peritonitis (3/232, 1.29%), and fever (16/232, 6.9%). Although the incidence of postoperative fever was notably higher in the predominantly extraluminal group (7/39, 17.9%) compared to the predominantly intraluminal group (9/193, 4.7%, <i>P</i> = 0.008), there were no significant differences in outcomes of the EFTR procedure. No instances of recurrence were observed during the mean follow-up period of 3.7 ± 2.3 years.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>EFTR was found to be feasible, safe, and effective for resecting upper GI SMTs, including lesions with predominantly extraluminal growth. Further validation in a prospective study is warranted.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 3","pages":"285-294"},"PeriodicalIF":5.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142195510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic clipping combined with cyanoacrylate injection vs. transjugular intrahepatic portosystemic shunt in the treatment of isolated gastric variceal bleeding: Randomized controlled trial 治疗孤立性胃底静脉曲张出血的内镜下夹闭联合氰基丙烯酸酯注射与经颈静脉肝内门体分流术的对比:随机对照试验
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-10 DOI: 10.1111/den.14916
Jing Li, Zhaoyi Chen, Yaxian Kuai, Fumin Zhang, Huixian Li, Derun Kong

Objectives

Although the incidence of isolated gastric varices type 1 (IGV1) bleeding is low, the condition is highly dangerous and associated with high mortality, making its treatment challenging. We aimed to compare the safety and efficacy of endoscopic clipping combined with cyanoacrylate injection (EC-CYA) vs. transjugular intrahepatic portosystemic shunt (TIPS) in treating IGV1.

Methods

In a single-center, randomized controlled trial, patients with IGV1 bleeding were randomly assigned to the EC-CYA group or TIPS group. The primary end-points were gastric variceal rebleeding rates and technical success. Secondary end-points included cumulative nonbleeding rates, mortality, and complications.

Results

A total of 156 patients between January 2019 and April 2023 were selected and randomly assigned to the EC-CYA group (n = 76) and TIPS group (n = 80). The technical success rate was 100% for both groups. The rebleeding rates were 14.5% in the EC-CYA group and 8.8% in the TIPS group, showing no significant difference (P = 0.263). Kaplan–Meier analysis revealed that the cumulative nonbleeding rates at 6, 12, 24, and 36 months for the two groups lacked statistical significance (P = 0.344). Similarly, cumulative survival rates at 12, 24, and 36 months for the two groups were not statistically significant (P = 0.916). The bleeding rates from other causes were 13.2% and 6.3% for the respective groups, showing no significant difference (P = 0.144). No instances of ectopic embolism were observed in either group. The incidence of hepatic encephalopathy (HE) in the TIPS group was statistically higher than that in the EC-CYA group (P = 0.001).

Conclusion

Both groups are effective in controlling IGV1 bleeding. Notably, EC-CYA did not result in ectopic embolism, and the incidence of HE was lower than that observed with TIPS.

目的虽然1型孤立性胃静脉曲张(IGV1)出血的发生率很低,但该病非常危险,死亡率很高,因此治疗难度很大。方法在一项单中心随机对照试验中,IGV1 型出血患者被随机分配到 EC-CYA 组或 TIPS 组。主要终点是胃静脉曲张再出血率和技术成功率。结果 在2019年1月至2023年4月期间,共挑选了156名患者,随机分配到EC-CYA组(n = 76)和TIPS组(n = 80)。两组的技术成功率均为 100%。EC-CYA组和TIPS组的再出血率分别为14.5%和8.8%,无显著差异(P = 0.263)。Kaplan-Meier 分析显示,两组患者在 6、12、24 和 36 个月的累积不出血率缺乏统计学意义(P = 0.344)。同样,两组患者在 12、24 和 36 个月的累积存活率也没有统计学意义(P = 0.916)。两组因其他原因引起的出血率分别为 13.2% 和 6.3%,无显著差异(P = 0.144)。两组均未观察到异位栓塞。TIPS 组的肝性脑病(HE)发生率在统计学上高于 EC-CYA 组(P = 0.001)。值得注意的是,EC-CYA 不会导致异位栓塞,而且 HE 的发生率低于 TIPS。
{"title":"Endoscopic clipping combined with cyanoacrylate injection vs. transjugular intrahepatic portosystemic shunt in the treatment of isolated gastric variceal bleeding: Randomized controlled trial","authors":"Jing Li,&nbsp;Zhaoyi Chen,&nbsp;Yaxian Kuai,&nbsp;Fumin Zhang,&nbsp;Huixian Li,&nbsp;Derun Kong","doi":"10.1111/den.14916","DOIUrl":"10.1111/den.14916","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Although the incidence of isolated gastric varices type 1 (IGV1) bleeding is low, the condition is highly dangerous and associated with high mortality, making its treatment challenging. We aimed to compare the safety and efficacy of endoscopic clipping combined with cyanoacrylate injection (EC-CYA) vs. transjugular intrahepatic portosystemic shunt (TIPS) in treating IGV1.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In a single-center, randomized controlled trial, patients with IGV1 bleeding were randomly assigned to the EC-CYA group or TIPS group. The primary end-points were gastric variceal rebleeding rates and technical success. Secondary end-points included cumulative nonbleeding rates, mortality, and complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 156 patients between January 2019 and April 2023 were selected and randomly assigned to the EC-CYA group (<i>n</i> = 76) and TIPS group (<i>n</i> = 80). The technical success rate was 100% for both groups. The rebleeding rates were 14.5% in the EC-CYA group and 8.8% in the TIPS group, showing no significant difference (<i>P</i> = 0.263). Kaplan–Meier analysis revealed that the cumulative nonbleeding rates at 6, 12, 24, and 36 months for the two groups lacked statistical significance (<i>P</i> = 0.344). Similarly, cumulative survival rates at 12, 24, and 36 months for the two groups were not statistically significant (<i>P</i> = 0.916). The bleeding rates from other causes were 13.2% and 6.3% for the respective groups, showing no significant difference (<i>P</i> = 0.144). No instances of ectopic embolism were observed in either group. The incidence of hepatic encephalopathy (HE) in the TIPS group was statistically higher than that in the EC-CYA group (<i>P</i> = 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Both groups are effective in controlling IGV1 bleeding. Notably, EC-CYA did not result in ectopic embolism, and the incidence of HE was lower than that observed with TIPS.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 3","pages":"275-284"},"PeriodicalIF":5.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14916","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142195511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical utility of linked color imaging in colonoscopy: Updated literature review 结肠镜检查中联动彩色成像的实用性:最新文献综述
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-10 DOI: 10.1111/den.14915
Fumiaki Ishibashi, Sho Suzuki

The remarkable recent developments in image-enhanced endoscopy (IEE) have significantly contributed to the advancement of diagnostic techniques. Linked color imaging (LCI) is an IEE technique in which color differences are expanded by processing image data to enhance short-wavelength narrow-band light. This feature of LCI causes reddish areas to appear redder and whitish areas to appear whiter. Because most colorectal lesions, such as neoplastic and inflammatory lesions, have a reddish tone, LCI is an effective tool for identifying colorectal lesions by clarifying the redder areas and distinguishing them from the surrounding normal mucosa. To date, eight randomized controlled trials have been conducted to evaluate the effectiveness of LCI in identifying colorectal adenomatous lesions. The results of a meta-analysis integrating these studies demonstrated that LCI was superior to white-light endoscopy for detecting colorectal adenomatous lesions. LCI also improves the detection of serrated lesions by enhancing their whiteness. Furthermore, accumulating evidence suggests that LCI is superior to white-light endoscopy for the diagnosis of the colonic mucosa in patients with ulcerative colitis. In this review, based on a comprehensive search of the current literature since the implementation of LCI, the utility of LCI in the detection and diagnosis of colorectal lesions is discussed. Additionally, the latest data, including attempts to combine artificial intelligence and LCI, are presented.

图像增强内窥镜(IEE)的最新发展极大地推动了诊断技术的进步。联动彩色成像(LCI)是一种 IEE 技术,通过处理图像数据来增强短波长窄带光,从而扩大色差。联动色彩成像的这一特点使偏红的区域看起来更红,偏白的区域看起来更白。由于大多数结直肠病变(如肿瘤性和炎症性病变)的色调偏红,LCI 可清晰显示偏红区域,并将其与周围正常粘膜区分开来,是识别结直肠病变的有效工具。迄今为止,已有八项随机对照试验对 LCI 识别结直肠腺瘤病变的有效性进行了评估。综合这些研究的荟萃分析结果表明,LCI 在检测结直肠腺瘤病变方面优于白光内窥镜检查。LCI 还能提高锯齿状病变的白度,从而提高病变的检出率。此外,越来越多的证据表明,LCI 在诊断溃疡性结肠炎患者的结肠粘膜方面优于白光内镜检查。在这篇综述中,基于对自 LCI 实施以来现有文献的全面检索,讨论了 LCI 在检测和诊断结直肠病变方面的实用性。此外,还介绍了最新的数据,包括将人工智能与 LCI 相结合的尝试。
{"title":"Practical utility of linked color imaging in colonoscopy: Updated literature review","authors":"Fumiaki Ishibashi,&nbsp;Sho Suzuki","doi":"10.1111/den.14915","DOIUrl":"10.1111/den.14915","url":null,"abstract":"<p>The remarkable recent developments in image-enhanced endoscopy (IEE) have significantly contributed to the advancement of diagnostic techniques. Linked color imaging (LCI) is an IEE technique in which color differences are expanded by processing image data to enhance short-wavelength narrow-band light. This feature of LCI causes reddish areas to appear redder and whitish areas to appear whiter. Because most colorectal lesions, such as neoplastic and inflammatory lesions, have a reddish tone, LCI is an effective tool for identifying colorectal lesions by clarifying the redder areas and distinguishing them from the surrounding normal mucosa. To date, eight randomized controlled trials have been conducted to evaluate the effectiveness of LCI in identifying colorectal adenomatous lesions. The results of a meta-analysis integrating these studies demonstrated that LCI was superior to white-light endoscopy for detecting colorectal adenomatous lesions. LCI also improves the detection of serrated lesions by enhancing their whiteness. Furthermore, accumulating evidence suggests that LCI is superior to white-light endoscopy for the diagnosis of the colonic mucosa in patients with ulcerative colitis. In this review, based on a comprehensive search of the current literature since the implementation of LCI, the utility of LCI in the detection and diagnosis of colorectal lesions is discussed. Additionally, the latest data, including attempts to combine artificial intelligence and LCI, are presented.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 2","pages":"147-156"},"PeriodicalIF":5.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14915","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142195513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified gel immersion method during endoscopic ultrasonography and injection sclerotherapy for esophageal varices 食管静脉曲张内窥镜超声波检查和注射硬化剂疗法中的改良凝胶浸泡法。
IF 5 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-09 DOI: 10.1111/den.14919
Koichi Soga, Ikuhiro Kobori, Masaya Tamano

Ruptured esophageal varices (EVs) lead to life-threatening events. Endoscopic injection sclerotherapy (EIS) can help prevent bleeding. Endoscopic ultrasound (EUS) is essential for evaluating EV hemodynamics to ensure their effective management. The gel immersion method (GIM), which is crucial for accurate diagnosis and management, provides a clear and stable medium in the gastrointestinal system.1 Compared with traditional water immersion techniques, the GIM provides superior image quality and reduces the risk of aspiration and other complications.2 A 75-year-old Japanese woman presented with an EV with enlarged and red color signs at risk of bleeding (Fig. 1a). Two consecutive EUS and EIS procedures were performed using the modified GIM (mGIM-EUS/EIS). During esophagoduodenoscopy, after general evaluation of the EV and deaeration of the stomach, gel (Viscoclear; Otsuka Pharmaceutical Factory, Tokushima, Japan) was injected into the esophagus. The EV was identified and the esophageal wall vessels (perforating veins) were penetrated using a 20 MHz ultrasonic mini probe (Fig. 1b) before mGIM-EIS. This method enabled a detailed hemodynamic evaluation of EV, including the assessment of perforating veins, to help estimate the difficulty of EIS.2, 3 mGIM-EIS was conducted without interruption. Filling the esophagus with intermittent gel supplementation prevented visual defects due to bleeding and improved procedural safety (Fig. 2a). The gel facilitated precise needle placement, effective delivery, and visualization of sclerosant agents into the varices, using balloon deployment to reduce the risk of aspiration (Fig. 2b–d, Video S1).3 The gel was injected through the working channel during the procedure. The absence of air in the esophagus and stomach reduced the patient burden. The gel used can be securely held in the esophagus, enabling mGIM-EUS/EIS procedures to be performed continuously and without stress. This method minimizes the risk of aspiration and ensures accurate and safe management during mGIM-EIS. Therefore, mGIM-EUS/EIS is more effective and safer than previous methods.

Authors declare no conflict of interest for this article.

食管静脉曲张破裂(EVs)可导致危及生命的事件。内镜注射硬化疗法(EIS)可以帮助预防出血。内镜超声(EUS)是评估EV血流动力学以确保其有效治疗的必要手段。凝胶浸泡法(GIM)为胃肠道系统提供了一种透明稳定的培养基,对准确诊断和治疗至关重要与传统的水浸泡技术相比,GIM提供了更好的图像质量,减少了误吸和其他并发症的风险一名75岁的日本女性表现为EV增大和红色征象,有出血风险(图1a)。使用改进的GIM (mmim -EUS/EIS)连续进行两次EUS和EIS手术。在食管十二指肠镜检查中,在对EV进行一般评估和胃通气后,凝胶(粘清;大冢制药厂,日本德岛)被注射到食道。在mgimm - eis之前,使用20 MHz超声微型探头(图1b)穿透食管壁血管(穿静脉)并确定EV。该方法可以对EV进行详细的血流动力学评估,包括对穿孔静脉的评估,以帮助评估eis的难度。间歇性补充凝胶填充食道可防止因出血导致的视力缺陷,并提高手术安全性(图2a)。凝胶有助于精确的针头放置,有效的输送,并可视化硬化剂进入静脉曲张,使用球囊部署来降低误吸的风险(图2b-d,视频S1)在手术过程中,凝胶通过工作通道注射。食管和胃内没有空气,减轻了病人的负担。所使用的凝胶可以安全地固定在食道中,使mgimm - eus /EIS手术可以连续进行,没有压力。这种方法最大限度地降低了误吸的风险,并确保了在mgimm - eis期间的准确和安全的管理。因此,mGIM-EUS/EIS比以往的方法更有效、更安全。作者声明本文不存在利益冲突。
{"title":"Modified gel immersion method during endoscopic ultrasonography and injection sclerotherapy for esophageal varices","authors":"Koichi Soga,&nbsp;Ikuhiro Kobori,&nbsp;Masaya Tamano","doi":"10.1111/den.14919","DOIUrl":"10.1111/den.14919","url":null,"abstract":"<p>Ruptured esophageal varices (EVs) lead to life-threatening events. Endoscopic injection sclerotherapy (EIS) can help prevent bleeding. Endoscopic ultrasound (EUS) is essential for evaluating EV hemodynamics to ensure their effective management. The gel immersion method (GIM), which is crucial for accurate diagnosis and management, provides a clear and stable medium in the gastrointestinal system.<span><sup>1</sup></span> Compared with traditional water immersion techniques, the GIM provides superior image quality and reduces the risk of aspiration and other complications.<span><sup>2</sup></span> A 75-year-old Japanese woman presented with an EV with enlarged and red color signs at risk of bleeding (Fig. 1a). Two consecutive EUS and EIS procedures were performed using the modified GIM (mGIM-EUS/EIS). During esophagoduodenoscopy, after general evaluation of the EV and deaeration of the stomach, gel (Viscoclear; Otsuka Pharmaceutical Factory, Tokushima, Japan) was injected into the esophagus. The EV was identified and the esophageal wall vessels (perforating veins) were penetrated using a 20 MHz ultrasonic mini probe (Fig. 1b) before mGIM-EIS. This method enabled a detailed hemodynamic evaluation of EV, including the assessment of perforating veins, to help estimate the difficulty of EIS.<span><sup>2, 3</sup></span> mGIM-EIS was conducted without interruption. Filling the esophagus with intermittent gel supplementation prevented visual defects due to bleeding and improved procedural safety (Fig. 2a). The gel facilitated precise needle placement, effective delivery, and visualization of sclerosant agents into the varices, using balloon deployment to reduce the risk of aspiration (Fig. 2b–d, Video S1).<span><sup>3</sup></span> The gel was injected through the working channel during the procedure. The absence of air in the esophagus and stomach reduced the patient burden. The gel used can be securely held in the esophagus, enabling mGIM-EUS/EIS procedures to be performed continuously and without stress. This method minimizes the risk of aspiration and ensures accurate and safe management during mGIM-EIS. Therefore, mGIM-EUS/EIS is more effective and safer than previous methods.</p><p>Authors declare no conflict of interest for this article.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"36 12","pages":"1386-1387"},"PeriodicalIF":5.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.14919","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1